Anna Gloyn, Professor of Paediatrics and Genetics at Stanford University, is a world leader in diabetes research. She has used human genetics as a tool to identify key molecular pathways which control glucose homeostasis and has consistently demonstrated how these insights can be translated into improvements in clinical care. Her groundbreaking early career discovery of the most common cause of neonatal diabetes remains one of the best examples of precision medicine.
She has made extraordinary contributions to our understanding of the molecular underpinnings of diabetes and has more broadly provided a framework for translation of genetic discoveries into molecular mechanisms and clinical insights of complex disease.